Clinical Trials Browser

Phase 4 × Cholangiocarcinoma × Folfox protocol × Clear all

NCT05124002 2024-03-04

Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma

Phase 4 Unknown

Gastrointestinal

Cholangiocarcinoma